Cited by 3,627Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, PJ, Price, DL, Struble, RG, Clark, AW, Coyle, JT, DeLong, Mahlon R.·1982·Science

Abstract

Recent evidence indicates that the nucleus basalis of Meynert, a distinct population of basal forebrain neurons, is a major source of cholinergic innervation of the cerebral cortex. Postmortem studies have previously demonstrated profound reduction in the presynaptic markers for cholinergic neurons in the cortex of patients with Alzheimer's disease and senile dementia of the Alzheimer's type. The results of this study show that neurons of the nucleus basalis of Meynert undergo a profound (greater than 75 percent) and selective degeneration in these patients and provide a pathological substrate of the cholinergic deficiency in their brains. Demonstration of selective degeneration of such neurons represents the first documentation of a loss of a transmitter-specific neuronal population in a major disorder of higher cortical function and, as such, points to a critical subcortical lesion in Alzheimer's patients.

Integrity signals

Registry

Crossref · 10.1126/science.7058341

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sst interneurons mediate the effects of arousal in cortical circuits under the effects of acetylcholine, which is also highly disrupted early in AD through the loss of cholinergic neurons in the basal forebrain.

    “Furthermore, they mediate the effects of arousal in cortical circuits92 under the effects of acetylcholine, which is also highly disrupted early in AD through the loss of cholinergic neurons in the basal forebrain93.”

    From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [93]

Cites

Flagged first, then by citations

Research works printed but not linked: 10

  1. Brody, H., Alzheimer's Disease: Senile Dementia and Related Disorders 7: 345 (1978).
  2. Coyle, J. T., Brain Neurotransmitters and Receptors in Aging and Age-Related Disorders: 149 (1981).
  3. DAVIS, K.L., BRAIN ACETYLCHOLINE: 205 (1979).
  4. DRACHMAN, D.A., AGING 7: 141 (1978).
  5. HASSLER, R, BEHAV AGING NERVOUS: 284 (1965).
  6. KUHAR, M.J., BIOL CHOLINERGIC FUN: 3 (1976).
  7. PARENT, A, ADVANCES IN NEUROLOGY 24: 1 (1979).
  8. TOMLINSON, B.E., DEMENTIA: 113 (1977).
  9. WANG, H, AGING DEMENTIA: 1 (1977).
  10. WANG, H.S., REPORT PANEL INFLAMM: 61 (1979).

Cited by

Sorted by citations

Authors
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R.
Affiliations
  • Johns Hopkins University (US)
  • Neuropathology Laboratory, Departments of Pathology and Neurology, Baltimore, Maryland 21205
  • Departments of Pharmacology and Experimental Therapy, Psychiatry, and Neuroscience, Baltimore, Maryland 21205
Venue
Science
Published
1982-03-05
Volume
215
Issue
4537
Pages
1237-1239
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2093374391
Cited by
3,627
References
44
Citations by year
2026: 52 · 2025: 42 · 2024: 53 · 2023: 67 · 2022: 62 · 2021: 91 · 2020: 95 · 2019: 66 · 2018: 63 · 2017: 66 · 2016: 82 · 2015: 65 · 2014: 73 · 2013: 63 · 2012: 56
FWCI
110.00
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Alzheimer's disease, senile dementia, nucleus basalis of Meynert, basal forebrain, cholinergic neurons, neuronal loss, cholinergic deficit, cerebral cortex, presynaptic markers, subcortical lesions
MeSH terms
Acetylcholine, Alzheimer Disease, Basal Ganglia, Dementia, Humans, Neural Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review